David Hallal

David Hallal has an estimated net worth of $214 Million. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., Kalaris Therapeutics, Inc., Seer, Inc., Scholar Rock Holding Corp, and ALEXION PHARMACEUTICALS INC.

2013 was David Hallal's most active year for acquiring shares with 13 total transactions. David Hallal's most active month to acquire stocks was the month of May. 2013 was David Hallal's most active year for disposing of shares, totalling 25 transactions. David Hallal's most active month to dispose stocks was the month of January. 2016 saw David Hallal paying a total of $18,360,960.00 for 192,136 shares, this is the most they've acquired in one year. In 2013 David Hallal cashed out on 281,713 shares for a total of $20,781,639.04, their largest year based on trade value.